Sinovac has published results showing that its vaccine has "largely protected" macaques from infection in an animal trial. The company has since conducted human trials, administering the serum on 144 volunteers in April in eastern Jiangsu province. PHASE 3 TRIALSThe firm will then move to phase three of the trials, which will determine whether the vaccine is effective among carriers of the virus. But Meng said the company is ready to collaborate with foreign partners which already buy its other vaccines against the flu and hepatitis. As it continues its research, the company is getting ready for mass production.

Source: Daily Nation April 30, 2020 10:52 UTC